University of California at Irvine and Swiss researchers eliminate brain tumors without damaging cognition
October 27,
2020
Irvine, California -- Treating cancer without
debilitating side effects has long been the holy grail of oncologists, and
researchers at the University of California, Irvine and Switzerland’s Lausanne
University Hospital/University of Lausanne (CHUV/UNIL) may have found it.
Charles
Limoli, professor of radiation oncology at UCI, and Marie-Catherine Vozenin,
associate professor of radiation oncology at CHUV/UNIL, used an ultra-high dose
rate of radiation therapy to eliminate brain tumors in mice, bypassing key side
effects usually caused by cranial irradiation. Their findings are published
in Clinical Cancer Research.
“It’s not
unreasonable to expect that in 10 years, this may become a widespread option
for radiotherapy patients worldwide,” Limoli said.
Traditional
radiation therapy exposes a tumor and nearby normal tissue to radiation for
several minutes at a time, but FLASH radiation therapy (FLASH-RT) allows
delivery of the same dose in only tenths of seconds. The speed eliminates many
of the toxicities that normally plague cancer survivors long after radiation
treatments, significantly decreasing side effects such as inflammation and
impairments to cognition.
As in
traditional radiation therapy, the researchers fractionated the dose – divided
the total over several sessions. Using FLASH-RT, they found that the same total
dose of radiation delivered at quicker dose rates removed brain tumors just as
effectively as the traditional method.
“This is very
important, since fractionation is the standard in the clinic and the easiest
way to transfer FLASH-RT at the clinical level,” said principal investigator
Vozenin, an adjunct professor at UCI.
Though this
work focused on the brain, FLASH-RT has also been used to treat lung, skin and
intestinal cancers, while still preventing many radiation-induced
complications. These additional studies have been successful across several
types of animals, including fish, mice, pigs, cats and one human subject.
“It seems
that this treatment is going to be universally beneficial for most cancer
types,” Limoli said.
Now that
researchers have verified that the method works, groups around the world are
developing machines that would make FLASH technology available in clinics. One
device is awaiting approval in the U.S. and Europe, and Vozenin plans to use it
in two clinical trials at CHUV early next year.
Meanwhile,
she and Limoli are investigating the mechanisms behind FLASH-RT’s beneficial
effects to better understand how the technology works.
Said Limoli:
“In the last 30 or 40 years, I’d say, there’s been nothing in the field of
radiation sciences as exciting as this.”
https://news.uci.edu/2020/10/27/cancer-treatment-without-side-effects/
No comments:
Post a Comment